Marie Gårdmark: Are FDA and EMA drifting apart?
26.09.11
Are FDA and EMA beginning to drift apart on what it takes to approve new medicines? And what could that mean for drug development on both sides of the Atlantic? Marie Gårdmark explores the question in a column.
Read more